Lilly Closes Its Singapore Drug Discovery Center; Is China Discovery Unit In The Works?
This article was originally published in PharmAsia News
Executive SummaryEli Lilly announced Oct. 18 that it will shut the doors of its eight-year-old Lilly Singapore Center for Drug Discovery
You may also be interested in...
Novartis plans to build a new center of excellence for biotechnology manufacturing costing more than $500 million, as it looks to leverage Singapore’s skilled labor force and proximity to growth markets like China.